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Abstract
Background: The MR-Egger (MRE) estimator has been proposed to correct for directional
pleiotropic effects of genetic instruments in an instrumental variable (IV) analysis. The
power of this method is considerably lower than that of conventional estimators, limiting
its applicability. Here we propose a novel Bayesian implementation of the MR-Egger esti-
mator (BMRE) and explore the utility of applying weakly informative priors on the inter-
cept term (the pleiotropy estimate) to increase power of the IV (slope) estimate.
Methods: This was a simulation study to compare the performance of different IV estima-
tors. Scenarios differed in the presence of a causal effect, the presence of pleiotropy, the
proportion of pleiotropic instruments and degree of ‘Instrument Strength Independent of
Direct Effect’ (InSIDE) assumption violation. Based on empirical plasma urate data, we
present an approach to elucidate a prior distribution for the amount of pleiotropy.
Results: A weakly informative prior on the intercept term increased power of the slope
estimate while maintaining type 1 error rates close to the nominal value of 0.05. Under
the InSIDE assumption, performance was unaffected by the presence or absence of plei-
otropy. Violation of the InSIDE assumption biased all estimators, affecting the BMRE
more than the MRE method.
Conclusions: Depending on the prior distribution, the BMRE estimator has more power
at the cost of an increased susceptibility to InSIDE assumption violations. As such the
BMRE method is a compromise between the MRE and conventional IV estimators, and
may be an especially useful approach to account for observed pleiotropy.
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Introduction
Instrumental variable analyses using genetic instruments,
often termed Mendelian randomization (MR) analyses, use
genetic exposures as instruments to determine the causal
association between an intermediate phenotype, often a
biomarker, and a particular outcome such as disease. The
estimate of such an MR analysis reflects an unbiased causal
estimate of the phenotype effect on the outcome, if (among
others) the following assumptions are met.
i. The instruments are associated with the phenotype.
ii. The instruments are independent of observed and un-
observed confounders of the phenotype-outcome
association.
iii. Conditional on the phenotype and confounders, the in-
struments are independent of the outcome (i.e. the ex-
clusion restriction assumption).
Given that biomarkers are the (indirect) products of mul-
tiple genes, it is often possible to select a set of genetic instru-
ments that meet assumption (i). Furthermore, because genes
are randomly allocated at conception,1 assumption (ii) is
often plausible as well. Assumption (iii) states that the genes
can only be related to disease due to their effects on the
phenotype (i.e. no pleiotropy other than that mediated by
the phenotype). Whether this assumption generally holds
has been contested.2 For example, if one is interested in esti-
mating the causal relation between high-density lipoprotein
cholesterol (HDL-C) and coronary heart disease (CHD), it is
often difficult to find genes that affect HDL-C but not low-
density lipoprotein cholesterol (LDL-C) or triglycerides.3,4
Such a situation may indicate violation of assumption (ii)
(when LDL-C is viewed as a confounder of HDL-C and
CHD), of assumption (iii) (when a gene effects both
pathways independently) or of both assumptions. In prac-
tice, such distinctions are difficult to make and hence robust
IV methods are preferred.
Recently Bowden et al.5 proposed a novel method
related to the Egger test,6 ‘Mendelian randomization
Egger’ (MR-Egger/MRE), which corrects for potential vio-
lations of assumption (iii) by quantifying the amount of
directional pleiotropy. This MR-Egger method assumes
that the ‘Instrument Strength is Independent of the Direct
Effect’ (i.e. the InSIDE assumption), which means that
across single nucleotide polymorphisms (SNPs), pleiotropic
effects are independent of phenotypic effects. The MR-
Egger method corrects for pleiotropy by introducing a
nuisance parameter which quantifies the average amount
of directional pleiotropy. However, including this nuisance
parameter greatly reduces precision and power to detect a
causal effect. Despite this reduced power, the MRE method
has been frequently used in empirical settings.4,7–9
In this paper, we propose a novel Bayesian implementa-
tion of the MR-Egger method, ‘BMR-Egger’, which in-
creases power of the causal estimate by introducing a
(weakly) informative prior on the nuisance parameter,
which is the intercept in a linear regression. From a
Bayesian perspective, the standard inverse variance
weighted (IVW) estimator and the MRE estimator can be
unified by noticing that the IVW method corresponds to
putting an optimistic informative prior on the intercept
with mean and variance of zero; conversely, the MRE ap-
proach can be seen as a pessimistic non-informative prior
with infinite variance. Whereas pessimistic and optimistic
priors are often used, for example in randomized con-
trolled trials (RCTs) in rare diseases,10 in genetics consider-
able data may be available on the magnitude of pleiotropy
Key Messages
• Absence of pleiotropy is an essential assumption for instrumental variable analyses using genetic instruments, known
as Mendelian randomization. The MR-Egger method corrects for the presence of pleiotropy by introducing a nuisance
parameter which captures directional pleiotropy. However, including this nuisance parameter greatly reduces power
to detect a causal effect as compared to the traditional inverse variance weighted (IVW) estimator.
• In this paper we propose a novel Bayesian implementation of the MR-Egger, ‘BMR-Egger’, which increases the power
of the causal estimate by introducing a weakly informative prior on the nuisance parameter. Our motivation is that
the BMR-Egger can be seen as a compromise between two extreme prior distributions. Specifically, the IVW method
corresponds to applying an optimistic informative prior on the intercept with a mean and variance of zero, whereas
MR-Egger corresponds to a pessimistic non-informative prior with an infinite variance.
• When the ‘Instrument Strength Independent of Direct Effect’ (InSIDE) assumption holds, the BMR-Egger has increased
power with acceptable type 1 error rates as compared to the MR-Egger. If the InSIDE assumption is violated, all esti-
mators are biased and show inappropriately high rejection rates. In this case, adding prior beliefs increases bias and
rejection rates of the BMR-Egger towards that of the IVW estimator.
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and consequently less extreme, more believable priors may
be usefully employed.
One reasonable approach may be a prior belief that ex-
treme departures from balanced pleiotropy are unlikely, as
strong pleiotropic effects of genetic variants may have been
previously identified. This is similarly optimistic to the
IVW method; however, instead of (unrealistically) assuming
a zero prior variance, we suggest use of weakly informative
priors to allow for a degree of pleiotropy. Alternatively, as
we will discuss using an empirical example of urate and
coronary heart disease (CHD),7 often considerable (aggre-
gated) data will be available on potential pleiotropic path-
ways, which can be used to further elucidate a prior
distribution to fit the specific data at hand. We note that
defining what constitutes a pleiotropic pathway is difficult
and will depend on subjective criteria such as statistical sig-
nificance and the availability of relevant datasets (such as
MR-base11).
In the following, we introduce notations, and the
outcome model, followed by a review of the MR estimators
and the proposed novel Bayesian MR estimator. Subsequently
we evaluate the discussed methods in a simulation study,
and the empirical example noted above.
Methods
Notation, and outcome model
Let us assume there are data available from j ¼ 1; . . . ; J in-
dependent single-nucleotide polymorphisms (SNPs) G
(an i ¼ 1; . . . ; n subject by J matrix), with aj representing
the (marginal) effect of SNP j on a biomarker X, bj the
(marginal) SNP effect on an outcome Y, and variance of
their estimators r2aj and r
2
bj
. We note that aj and bj may be
estimated from the same data (one-sample MR study) or in
separate data (two-sample MR study); we focus on the lat-
ter.12 Based on these data we are interested in estimating
the causal effect of X on Y, assuming Y is generated by
the linear model Yi ¼
PJ
j/jGij þ hXi þ ey, with h a scalar,
and Y;G and X as defined above. When assumptions (ii–iii)
hold, /j ¼ 0 and Yi ¼ hXi þ ey. Note that the absence of
an intercept term in the above equations should be inter-
preted as meaning the intercept (arbitrarily) equals zero,
and should not be misinterpreted as an absence of plei-
otropy which is represented by /j:
MR estimators
When there are multiple instruments available, the causal
(IV) effect of X on Y can be estimated using a weighted or-
dinary least squares (OLS) regression of bj on aj while
supressing the intercept. Given that bj and aj are unknown,
they are estimated from the data, with the estimates col-
lected in the following matrices:
A ¼
a^1
..
.
a^J
2
64
3
75;
B ¼
b^1
..
.
b^J
2
664
3
775;
Xjk ¼ r^bj r^bkpjk;
where X is the sample variance-covariance matrix for B,
with pj¼k ¼ 1 and, assuming that SNPs are independent,
pj6¼k ¼ 0. In the case of correlated SNPs, pj 6¼k can be esti-
mated based on the pairwise between SNP correlations13
and the regression fitted by generalized least squares. The
following regression is weighted by the precision of the
SNP effect estimates, giving the IVW point estimate and
standard error estimates (assuming no pleiotropy, or bal-
anced positive and negative pleiotropic effects under the
InSIDE assumption)14 as:
h^IVW ¼ ðAtX1AÞ1AtX1B; (1)
with the weighted residuals:
e^j ¼ diagðX1Þ
1
2ðB h^IVWAÞ;
where diagðÞ indicates the diagonal elements. The variance
of the error term is then:
r^2e ¼
1
J  kþ
XJ
j ¼ 1
e^2j ;
where k equals the number of parameters (k ¼ 1 in this
specific case). Finally, the standard error of the slope is:
r^hIVW ¼ diag

r^2e ðAtX1AÞ1
1
2
: (2)
Here, and in the following derivations, the sigma term
r^2e will only be included if it is larger than 1, resulting in
standard errors following a multiplicative random effects
model.15
The MR-Egger method corrects for (unmeasured) dir-
ectional pleiotropy by introducing an intercept term
which captures the expected effect of an instrument on
outcome when it has no effect on the biomarker, and is
hence a measure of the average amount of pleiotropy. To
implement the MR-Egger we first recode the data as
follows:
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b^

j ¼ b^jsgnða^jÞ;
with sgn the sign function;
a^j ¼ ja^jj;
A ¼
1 a^1
..
. ..
.
1 a^J
2
664
3
775;
B ¼
b^

1
..
.
b^

J
2
664
3
775
/^MRE
h^MRE
" #
¼ ðAtX1AÞ1AtX1B;
r^/MRE
r^hMRE
" #
¼ diag

r^2e ðAtX1AÞ1
1
2
;
with r^2e derived as before, h^MRE the slope estimate, and
/^MRE the intercept estimate.
Next, we describe our proposed Bayesian MR-Egger
method [BMRE] using a bivariate normal likelihood
and the conjugate prior distribution with hyperpara-
meters for the prior mean and variance of the intercept
and slope:
l0 ¼
l/
lh
 
R0 ¼
r2l/ 0
0 r2lh
2
4
3
5:
Then the posterior distribution is bivariate normal with
mean lN and variance-covariance matrix RN:
k0 ¼ R10 ;
lN ¼ ðAtX1Aþ k0Þ1ðk0lt0 þ AtX1BÞ;
RN ¼ r^2e ðAtX1Aþ k0Þ1;
with r^2e derived as before.
To explore the effect of including prior information using
weakly informative priors, we performed the simulation
study described below. Specifically, we were interested in
exploring the advantage of specifying a prior on the intercept
/^BMRE to increase precision of the posterior h^BMRE and on
the robustness of prior misspecification. In our empirical ex-
ample, we illustrate how to use empirical data on observed
pleiotropy signals to elucidate reasonable priors, decreasing
the likelihood of prior misspecification.
Our results will also discuss a further method to allow
for pleiotropy, the weighted median (WM) estimator.16
This estimator assumes that at least 50% of the weights,
wj ¼ a^
2
j
r^2bj
, come from valid instruments. If this assumption is
true, a consistent estimate of causal effect is the 50th per-
centile of the empirical distribution function of SNP-
specific IV estimates
a^ j
b^ j
, with the percentile distribution
based on
sj
wj
2
S ; where sj ¼
Pj
k ¼ 1wk, the cumulative sum
up to the jth SNP, and S ¼ PJk ¼ 1wk.
Data-generating process
Similar to the original publication by Bowden et al.,5 data for
i ¼ 1; . . . ; n subjects were simulated, with n ¼ 1000
and J ¼ 20 SNPs. Gij were sampled from a trinomial distri-
bution with minor allele frequency pj ¼ 0:30 under Hardy–
Weinberg equilibrium. An unmeasured confounder was
generated based on Ui ¼
PJ
jx1jGij þ u; u  Nð0; 2Þ
and a biomarker Xi ¼
PJ
jajGij þ x2Ui þ x; x  Nð0; 2Þ:
Finally, the outcome was generated following Yi ¼
PJ
j/jGij
þhXi þ x3Ui þ y; y  Nð0; 2Þ: Based on the two-sample
MR principle,12 this algorithm was run twice (with the same
parameters) to generate two independent datasets, the first
used to derive the genetic effects on the biomarker by fitting
the linear model Xi ¼ ajGij þ x, and the second to estimate
the genetic effects on the outcome from the linear model
Yi ¼ bjGij þ y.
Simulation scenarios
The above defined MR estimators were evaluated in five
scenarios (Table 1). In scenario I there was no pleiotropy,
hence /j ¼ 0, and the confounder was independent of
the SNPs, x1j ¼ 0. In scenario II pleiotropy was gener-
ated based on /j  Uð0:00; 0:20Þ, and in scenario III the
InSIDE assumption was violated by setting x1j  UðL;UÞ;
L ¼ 0;U ¼ 0:50: In scenario IV the InSIDE assumption
was met, x1j ¼ 0, and pleiotropy was generated based on
/j  Uð0:00; 0:50Þ with probability q ¼ f0:1; 0:2; 0:3;
0:4g and 0 otherwise, resulting in (on average) qJ SNPs
violating assumption (iii). In this scenario the average
pleiotropy depends on q and ranged between Eð/jÞq
¼ f0:025; . . . ; 0:100g. Subsequently, in scenario V q
¼ 0:4 with /j and x1j generated based on q as in scenario
IV. Different types and severities of InSIDE assumption
violations were generated by first setting L ¼ 0 and B
¼ f0:10; 0:30; 0:60; 1:00g, and subsequently setting L
¼ B and B ¼ f0:10; 0:30; 0:60; 1:00g. All scenarios
were repeated under the null- and alternative-hypotheses
setting h ¼ f0:00; 0:05g: The BMRE estimator was
evaluated using the following hyperparameters:
l/ ¼ f0; 0:05; 0:10; 0:15g; lh ¼ 0, with every elem-
ent of l/ evaluated with five different variance hyperpara-
meters: r2l/ ¼ f10; 10
2; 102:4; 102:7; 103g, and
r2lh ¼ 10.
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Performance metrics
Performance was evaluated using the following metrics:
bias defined as h  h, with h equal to the mean of h^; the
root mean square error RMSE ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃbias2 þ ESE2p ; with
ESE equal to the empirical standard error of h^: the propor-
tion of rejected null-hypotheses (i.e. depending on whether
h equals 0 this is the type 1 error or power, using an alpha
of 0.05).
All simulations were repeated 5000 times, with analyses
performed using the statistical package R version 3.1.2 for
Unix.17 The number of replications was chosen to ensure
sufficient precision to detect small deviations from the
nominal type 1 error rate of 0.05 (the 95% lower and
upper bounds were 0.044 and 0.056).
Results
Results of the simulation study
In scenario I all the MR assumptions held, hence all the
IVW, WM and MRE estimators were unbiased (Appendix
Figures 1–2, available as Supplementary data at IJE on-
line). Bias of the BMRE estimates was minimal for the
hyperparameters l0 ¼ f0:00; 0:05g, irrespective of
the variance hyperparameter. Type 1 error rates of both
the intercept and the slope estimates were generally below
0.05 using the same priors, and the RMSE markedly
decreased with smaller values of r2l/ (Figure 1). Repeating
scenario 1 with the true slope set to 0.05, revealed that
power of the BMRE estimator (relative to the MRE) was
increased without increasing the intercept type 1 error rate
above 0.05, unless l/0:1 and then only for small values
of r2l/ (Figure 2).
Scenario II explored performance in the presence of
pleiotropy which biased the IVW estimates, and (because
100% of the SNPs were pleiotropic) the WM. The MRE
estimator remained unbiased (Appendix Figures 5–6, avail-
able as Supplementary data at IJE online), with the BMRE
showing a similar pattern of bias as before, with bias de-
pending on the size of r2l/ when l/ 6¼ 0:10: Intercept rejec-
tion rates (power) were increased when l/0:10 and
r2l/ 6¼ 10
1; slope rejection rates (type 1 error) were close to
nominal for all BMRE using r2l/10
2:4 (Appendix Figure
7, available as Supplementary data at IJE online). In the
same scenario (Appendix Figure 7) the type 1 error rates of
the IVW estimator, and (to a lesser extent) the WM estima-
tor, were inflated, at 0.73 and 0.44 respectively. Setting the
phenotype effect to 0.05 (Figure 3) showed that power of
the slope estimate was improved even when l/ was misspe-
cified (i.e. not 0.10). Throughout the RMSE of the BMRE,
estimators were equal to or lower than for the MRE
estimator.
The InSIDE assumption was violated in scenario III
which biased all estimators, with the more informative
BMRE faring similarly to the IVW or WM estimators
(Appendix Figures 9–10, available as Supplementary data
at IJE online). Whereas the type 1 error rates of the IVW
and WM estimators were close to 100%, the BMRE rejec-
tion rates depended on r2l/ and often less than the IVW or
WM methods (Figure 4). The MRE estimator had only
Table 1. Simulation scenarios of a multi-SNP Mendelian randomization study, with potential pleiotropic effects (i.e. violation of
the exclusion restriction assumption)a
Parameters Scenario I Scenario II Scenario III Scenario IV Scenario V
(no pleiotropy) (pleiotropy) (InSIDE
violated)
(partial
pleiotropy)
(partial pleiotropy and
InSIDE violated)
Number of subjects n 1000 1000 1000 1000 1000
Number of SNPs J 20 20 20 20 20
Proportion of pleiotropic SNPs q 1.0 1.0 1.0 {0.1, 0.2, 0.3, 0.4} 0.4
Minor allele frequency pj 0:30 0:30 0:30 0:30 0:30
Effect of Gj on Ui ðx1jÞ 0:00 0:00 Unif ðL;UÞ 0:00 Unif ðL;UÞ
Lower limit of x1j L L ¼ 0:00 L ¼ 0
B ¼ f0:10; 0:30; 0:60; 1:0g; and
Upper limit of x1j U U ¼ 0:50 L ¼ B
B ¼ f0:10; 0:30; 0:60; 1:0g
Effect of Gj on Xi ðajÞ Unif ð0:5; 4Þ Unif ð0:5; 4Þ Unif ð0:5; 4Þ Unif ð0:5; 4Þ Unif ð0:5; 4Þ
Effect of Gj on Yi ð/jÞ 0:00 Unif ð0; 0:2Þ Unif ð0; 0:2Þ Unif ð0; 0:2Þ Unif ð0; 0:2Þ
Effect of Ui on Xi ðx2Þ 1 1 1 1 1
Effect of Ui on Yi ðx3Þ 1 1 1 1 1
Effect of Xi on Yi ðhÞ f0:00; 0:05g f0:00; 0:05g f0:00; 0:05g f0:00; 0:05g f0:00; 0:05g
aChanges from the previous scenario (to the left) are presented in bold.
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Figure 1. Rejection rate and root mean squared error of a Mendelian randomization study (scenario I) with the true slope of 0 and no unbalanced plei-
otropy. IVW, inverse variance weighted; WM, weighted median; MRE, MR-Egger; l/ indicates the prior mean, and r
2
l/
the prior variance of a Bayesian
MRE. The underlying numerical values are presented in Appendix 3, available as Supplementary data at IJE online.
Figure 2. Rejection rate and root mean squared error of a Mendelian randomization study (scenario I) with the true slope of 0.05 and no unbalanced
pleiotropy. IVW, inverse variance weighted; WM, weighted median; MRE, MR-Egger; l/ indicates the prior mean, and r
2
l/
the prior variance of a
Bayesian MRE. The underlying numerical values are presented in Appendix 3, available as Supplementary data at IJE online.
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slightly inflated type 1 error rates close to 0.05. The bias
and inflated type 1 error rate of the BMRE persisted even
when the intercept prior mean was correctly specified at
0.10 (Figure 4). In these settings, the BMRE estimator was
generally more powerful than the MRE approach, which is
of limited value given the observed bias and inflated type 1
error rates (Appendix Figure 12, available as Supplementary
data at IJE online).
The performance of these estimators was further
explored in scenario IV by varying the proportion of pleio-
tropic SNPs. The BMRE results focused on the previously
optimally performing combinations of hyperparameters:
l/ ¼ f0; 0:05; 0:10g; r2l/ ¼ f 10
2; 102:4g. Note that in
this and the next scenario, the average pleiotropy depends
on the proportion of pleiotropic SNPs, which ranged be-
tween 0.025 (for 10% invalid SNPs) and 0.100 (for 40%
invalid SNPs), resulting in differing levels of BMRE mis-
specification. Figure 5 shows the MRE to be the only un-
biased estimator in this scenario. Type 1 error rates were
inflated for the IVW and WM methods, with power of the
BMRE approach typically surpassing that of the MRE esti-
mator. Next in scenario V, we explored the impact of dif-
ferent degrees of InSIDE assumption violation, revealing a
similar amount of bias for all estimators (Figure 6). Type 1
error rates and power were general highest for the IVW,
(closely) followed by WM, the BMRE and MRE methods.
As before, the MRE had the largest RMSE throughout,
with smaller values for the BMRE, IVW and the WM
estimators.
Prior elucidation using empirical data
To illustrate the proposed BMRE method and provide an
example of how to elucidate a sensible prior distribution,
we consider the study by White et al.7 This study explored
the relation between urate and CHD using 31 SNPs col-
lected from 166 486 individuals, 9784 of whom had CHD.
White and colleagues used both the IVW and the MRE
methods, which showed conflicting results: odds ratio
(OR) 1.18 (95% confidence interval (CI) 1.03; 1.34) for
the IVW estimate compared with OR 1.05 (95% CI 0.87;
1.27) for the MRE estimate; both re-calculated here using
a pleiotropy robust multiplicative random effects model.
Aside from the difference in point estimate, the MRE esti-
mate is considerably more variable (standard error (se) of
0.096, compared with an IVW se of 0.066), resulting in
wide confidence interval bounds. Interestingly the MRE
pleiotropy (intercept) OR estimate of 1.008 (95% CI
0.998; 1.018) is precise, seemingly indicating that amount
of directional pleiotropy is minimal, thus questioning the
Figure 3. Rejection rate and root mean squared error of a Mendelian randomization study (scenario II) with the true slope of 0.05 and unbalanced
pleiotropy. IVW, inverse variance weighted; WM, weighted median; MRE, MR-Egger; l/ indicates the prior mean, and r
2
l/
the prior variance of a
Bayesian MRE. The underlying numerical values are presented in Appendix 3, available as Supplementary data at IJE online.
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necessity of a MRE pleiotropy correction. In the following,
we will explore the utility of the BMRE to increase preci-
sion of the slope estimate and further explore the necessity
of the pleiotropy correction.
White and colleagues not only collected data on CHD
and urate, but also on many potential pleiotropic pathways
(Appendix Figure 13, available as Supplementary data at
IJE online) allowing a thorough exploration of the magni-
tude and direction of observed pleiotropy. We note that
four SNPs (rs1260326, rs3741414, rs1178977, rs653178)
show clear pleiotropic signals (based on a genome-wide
significant P-value). Given the number of candidate SNPs,
it would be sensible to exclude these SNPs; however, to il-
lustrate the utility of the BMRE we will include these
SNPs. Inclusion of pleiotropic SNPs may also occur in
practice, for example, when the number of candidate SNPs
is modest. Additionally, there is no a priori reason to as-
sume pleiotropy is limited to genome-wide significant sig-
nals, hence exclusion of these four SNPs will not
necessarily remove all (or even most) of the pleiotropy.
To elucidate and model the likely (known and un-
known) pleiotropic effects, we plot the SNP associations
with the different phenotypes (Appendix Figure 13), which
shows a symmetrical (balanced) pattern centred on a null
effect, with most of the estimates between 6 0.05.
Although reassuring, this does not preclude the possibility
of unobserved pleiotropy via different pathways. Based on
the observed pleiotropy effects (Appendix Figure 13), we
set the mean prior hyperparameter to l/ ¼ 0:00 and con-
sidered the following prior variance hyperparameters:
r2l/ ¼ f10
6; 105:8; 105:6; 105:4; 105:2g. These
values of the prior variance parameters were chosen to ini-
tially approximate the IVW estimator, incrementally
including more uncertainty and thereby allowing for add-
itional pleiotropy. Second, in an alternative approach we
use the empirical data to also elucidate the prior variance
hyperparameter by selecting a prior variance r2l/ ¼
6:508 104  103:2, putting approximately 95% of the
prior distribution 6 0.05 (the range containing most of the
observed pleiotropy signals).
Results of the first approach are shown in Table 2, with
the BMRE method showing larger slope estimates (OR
ranges from 1.17 to 1.13), than the attenuated MRE OR
estimate of 1.05 and the WM 1.12 (95% CI 0.99; 1.27).
The BMRE credible intervals included the neutral value of
1 at a prior variance of 105:6; under this prior the inter-
cept odds has 95% probability of lying in (0.997,1.003)
suggesting that the balanced pleiotropy assumption has a
relevant impact on our IV estimates. Similarly when using
the empirically elucidated variance hyperparameter of
Figure 4. Rejection rate and root mean squared error of a Mendelian randomization study (scenario III) with the true slope of 0.05, and InSIDE as-
sumption violated. IVW, inverse variance weighted; WM, weighted median; MRE, MR-Egger; l/ indicates the prior mean, and r
2
l/
the prior variance
of a Bayesian MRE. The underlying numerical values are presented in Appendix 3, available as Supplementary data at IJE online.
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6:508 104; the BMRE slope estimate becomes OR 1.05
(95% CI 0.87; 1.27) which is identical (to 2 dp) to the
MRE estimate. Using the BMRE method we can thus con-
fidently say that despite the empirical data showing bal-
anced pleiotropy, and the tight confidence interval around
the MRE intercept estimate, there is relevant directional
pleiotropy and the pleiotropy-corrected estimates should
be preferred over the IVW estimate.
Discussion
In this paper, we introduce a novel Bayesian implementa-
tion of the MR-Egger (BMRE) method for instrumental
variable analyses, robust to violation of the exclusion re-
striction assumption due to pleiotropy. We show that
under the InSIDE assumption, the BMRE estimator with
weakly informative priors on the intercept increases power
to detect a causal effect, while retaining acceptable type 1
error rates. Additionally, the root mean square error of the
BMRE estimator was lower than that of the traditional
MRE method and, in the presence of pleiotropy, lower
than the IVW estimator. Using the empirical example of
urate and CHD, we present an approach to evaluate and
elucidate sensible prior parameters for the presence of
pleiotropy.
When the InSIDE assumption was violated, all estima-
tors were biased and showed inappropriately high rejection
rates. In this case, adding prior belief increased bias and re-
jection rates of the BMRE towards those of the IVW esti-
mator. Comparing the BMRE with the WM method
showed that (depending on the prior) the BMRE approach
had lower type 1 error rates and was more robust to differ-
ent degrees of InSIDE assumption violation. Furthermore,
if 100% of the SNPs were pleiotropic, the BMRE approach
generally was less biased, with type 1 error rates closer to
nominal than the WM estimator. In the presence of InSIDE
Figure 5. Simulation results of scenario IV: the causal effect estimated in Mendelian randomization study with different proportions of pleiotropic
SNPs. IVW, inverse variance weighted; WM, weighted median; MRE, MR-Egger; l/ indicates the prior mean, and r
2
l/
the prior variance of a Bayesian
MRE. The underlying numerical values are presented in Appendix 3, available as Supplementary data at IJE online.
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assumption violation, the MRE estimator performed better
than the BMRE method. The InSIDE assumption may be
violated in empirical data, for example when the plei-
otropy effects of different variants affect the outcome via
the same set of confounders. Pickrell et al., however, pre-
sent evidence that pleiotropic SNPs often work via inde-
pendent pathways, suggesting the InSIDE assumption may
hold more generally.18
The analyses presented here are naturally limited and
the following deserves consideration. First, we chose to im-
plement the BMRE using conjugate priors because these
have closed form solutions which increase ease of use and
provide exact solutions. In most empirical settings, conju-
gate priors seem sufficient and are a natural way to encode
prior knowledge. Furthermore, the normal distribution is
not sharply peaked at its mean value, allowing a reason-
able range of values to be given high prior probability,
while still discounting unreasonably large values. Second,
whereas the IVW method is susceptible to directional plei-
otropy, this estimator generally has more precision and
power and is more robust to uncertainty in the SNP-
exposure association.19 As such, the IVW method should,
Table 2. Results of a Mendelian randomization study on the
effect of plasma urate on CHD with different IV estimators
Estimates
Intercept Slope
OR (95% CI) OR (95% CI)
IVW
1.18 (1.03; 1.34)
MRE
1.008 (0.998; 1.018) 1.05 (0.87; 1.27)
BMRE
r2/ ¼ 106 1.001 (0.998; 1.003) 1.17 (1.02; 1.34)
r2/ ¼ 105:8 1.001 (0.998; 1.004) 1.16 (1.01; 1.34)
r2/ ¼ 105:6 1.001 (0.997; 1.006) 1.15 (1.00; 1.33)
r2/ ¼ 105:4 1.002 (0.997; 1.007) 1.14 (0.99; 1.33)
r2/ ¼ 105:2 1.003 (0.997; 1.009) 1.13 (0.97; 1.32)
WM 1.12 (0.99; 1.27)
Results presented as odds ratio per 1 SD increase in urate with 95% confi-
dence (or credibility) interval (CI) in brackets. The intercept measures the
amount of pleiotropy, the slope estimates the effect of plasma urate on CHD.
IVW, inverse variance weighted method; MRE, MR-Egger method; BMRE,
Bayesian MR-egger method; WM, weighted median method. l/ ¼ 0, the
slope mean and variance priors were 0 and 10 throughout, respectively.
Figure 6. Simulation results of scenario V: the causal effect estimated in a Mendelian randomization study with 40% pleiotropic SNPs and different
degrees of InSIDE assumption violation; left panel: no causal effect; right panel: causal effect of 0.05. IVW, inverse variance weighted; WM, weighted
median; MRE, MR-Egger; l/ indicates the prior mean, and r
2
l/
the prior variance of a Bayesian MRE. The underlying numerical values are presented
in Appendix 3, available as Supplementary data at IJE online.
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in our opinion, remain the starting point of any MR ana-
lysis, with other approaches including the WM, MRE and
BMRE used as informative sensitivity analyses. Third, the
BMRE methods were evaluated on frequentist concepts of
power and type 1 error. Given that MR analyses are often
used to test whether a biomarker has a causal effect on dis-
ease, we feel these metrics are relevant. Fourth, whereas
the weakly informative hyperparameter of l/ ¼ f0:00;
0:05g and r2l/10
2:4 had the desired property of increas-
ing power while maintaining type 1 error rates close to
nominal, this is specific to the scenarios considered.
Indeed, as we show in our empirical example, these prior
hyperparameters should be tailored to the data under con-
sideration. We encourage empirical researchers to use our
example as a blueprint to explore observed pleiotropy and
to tailor the hyperparameters. In practice, analyses should
be repeated under a range of variance hyperparameters, to
gain a sense of how precise the prior beliefs must be to
maintain significant evidence of causality. Additionally,
and similar to designing a Bayesian randomized controlled
trial, one may wish to repeat the simulations using scen-
arios based on the available empirical data and explore
performance (see Appendix 2 for the simulation code
which took 42 s to run 500 replications of scenario II).
The BMRE method can be used to explore the importance
of the balanced pleiotropy assumption of the IVW estimator,
and may be particularly useful for reconciling conflicting re-
sults from IVW and MRE methods, as we have shown in our
example of urate and CHD. Applied researchers may wish to
look to a recent framework14 reviewing the underlying as-
sumptions of the IVW and MRE methods, as well as describ-
ing a number of goodness-of-fit statistics and sensitivity
analyses. By using a conjugate Bayesian prior, the same
framework can readily be applied to the BMRE method pre-
sented here. Similarly, the SIMEX19 adjustment for uncer-
tainty in the SNP-exposure association can be readily applied
to our BMRE method as well.
In addition to MRE and WM methods, several other
approaches to deal with pleiotropy have recently been pro-
posed, each with its own assumptions, including a
weighted mode estimator20 and a Bayesian model averag-
ing21 approach conceptually similar to ours. Furthermore,
detection and removal of SNPs yielding outlier IV esti-
mates is an important step that can be combined with the
pleiotropy robust estimators.14 A full comparison of meth-
ods under realistic settings is beyond the scope of this
paper, but a sensible strategy in general is to perform a ser-
ies of complementary sensitivity analyses in addition to the
standard IVW analysis. In this regard, our BMRE method
can increase the precision of the MRE estimator and pro-
vide insight into discrepancies between IVW and MRE
analyses. Further, our BMRE method may be especially
useful when candidate instruments show likely pleiotropic
effects, but there are too few strong instruments to exclude
these pleiotropic SNPs.
In conclusion, we introduce a Bayesian version of the
MR-Egger method, which, by placing weakly informative
priors on the intercept term increases power over MR-
Egger while retaining acceptable type 1 error rates.
Violations of the InSIDE assumption increase bias and type
1 error rates beyond those of the MR-Egger method. We
suggest that Bayesian MR-Egger is a useful sensitivity ana-
lysis that can strengthen the evidence for causal effects in
MR studies, particularly in the presence of observed
pleiotropy.
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